Biocardia to participate in upcoming heart and pulmonary therapy development symposia

Sunnyvale, calif., july 12, 2022 (globe newswire) -- biocardia®, inc. [nasdaq: bcda], sunnyvale, calif. – biocardia®, inc. [nasdaq: bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced that company's ceo peter altman has been invited to participate at two upcoming therapeutic development symposia.
BCDA Ratings Summary
BCDA Quant Ranking